During the past decade, Neurology Clinic and National Center for Tumor Diseases conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Clinic and National Center for Tumor Diseases" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Ruhr University of Bochum" with 1 trials as a collaborator and "Universitätsmedizin Mannheim" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Clinic and National Center for Tumor Diseases" are "Glioblastoma" (1 trials), "Glioblastoma Multiforme" (1 trials), "Oligodendroglioma" (1 trials) and "Recurrent Glioblastoma" (1 trials). Many other conditions were trialed in "Neurology Clinic and National Center for Tumor Diseases" in a lesser frequency.

Most popular intervention types in "Neurology Clinic and National Center for Tumor Diseases" are "Drug" (3 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "VXM01" (2 trials), "Avelumab" (1 trials), "BIBF 1120" (1 trials), "CETEG" (1 trials) and "PCV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Clinic and National Center for Tumor Diseases" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Clinic and National Center for Tumor Diseases". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neurology Clinic and National Center for Tumor Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Clinic and National Center for Tumor Diseases, 3 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".